Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The study will test:
1. whether estrogen treatment in transwomen is associated with improved insulin sensitivity
and beta cell function
2. whether testosterone treatment in transmen is associated with worsening insulin
sensitivity and beta cell function
3. whether estrogen therapy leads to enhanced immune response in older transwormen
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborator:
Foundation for advancing Veterans Health Research (FAVHR)